CYTOKINETICS INC — Director's Dealing 2017

Jun 30, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2017-06-30

Reporting Person: Jaw Ching (SVP Finance & CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-30	Incentive Stock Option (right to buy)	$12.1	A	33056	Acquired	2027-06-30	Common Stock (33056)	Direct
2017-06-30	Non-Qualified Stock Option (right to buy)	$12.1	A	41944	Acquired	2027-06-30	Common Stock (41944)	Direct

Footnotes

F1: When the ISO and NQ dated 06/30/17 are combined for a total grant of 75,000 shares, the option shall vest and become exercisable as to 18,750 shares on 06/30/18 and the balance of 56,250 divided into equal monthly installments thereafter such that the option shall be 100% vested on 06/30/21.